CNO Financial Group (NYSE:CNO) Analyst Rating Consensus

CNO Financial Group (NYSE:CNO) has received a short term rating of sell from experts at Zacks with a rank of 4. The stock has been rated an average of 2.4 by 5 Brokerage Firm. 1 Wall Street Firms have rated the stock as a strong buys. 1 stock experts have also suggested a buy rating. 3 Brokerage Firms have advised hold.

CNO Financial Group (NYSE:CNO) should head towards $20.75 per share according to 4 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $20 per share. The higher price estimate target is at $22 according to the Analysts.

CNO Financial Group (NYSE:CNO) rose 0.16% or 0.03 points on Tuesday and made its way into the gainers of the day. After trading began at $18.89 the stock was seen hitting $18.905 as a peak level and $18.65 as the lowest level. The stock ended up at $18.82. The daily volume was measured at 1,289,180 shares. The 52-week high of the share price is $20.88 and the 52-week low is $14.66. The company has a market cap of $3,371 million.

Shares of CNO Financial Group, Inc. appreciated by 1.62% during the last five trading days but lost 3.64% on a 4-week basis. CNO Financial Group, Inc. is up 2.14% in the last 3-month period. Year-to-Date the stock performance stands at -0.64%.

CNO Financial Group, Inc. is a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products. The Company manages its business through three operating segments: Bankers Life, Washington National and Colonial Penn. Bankers Life markets and distributes Medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products. Washington National markets and distributes supplemental health, including specified disease, accident and hospital indemnity insurance products, and life insurance. Colonial Penn markets primarily graded benefit and simplified issue life insurance.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.